Home LiteratureArticle Details
PMID: 11232598 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S. Review

RyR1 modulation by oxidation and calmodulin.

Antioxidants & redox signaling ·Vol. 2 ·No. 1 ·2000-00-00 ·Pages 41-5

Hamilton SL, Reid MB

Abstract

Alteration of skeletal muscle function by reactive oxygen species and nitric oxide (NO) may involve regulation of the activity of the skeletal muscle Ca2+ release channel (also known as RyR1). We have shown that oxidants can activate RyR1 and produce inter-subunit disulfide bonds. Both effects are prevented by pretreatment with either NO donors or N-ethylmaleimide under conditions that modify less than 5% of the total sulfhydryls on RyR1. Oxidation-induced intersubunit crosslinking can also be prevented by the binding of either Ca2+ calmodulin or apocalmodulin to RyR1. Also, both Ca2+ calmodulin and apocalmodulin binding are blocked by oxidation of RyR1. In contrast, alkylation with N-ethylmaleimide or reaction with NO donors preferentially blocks apocalmodulin binding to RyR1, suggesting the existence of a regulatory cysteine within the apocalmodulin binding site. We have demonstrated that Ca2+ calmodulin and apocalmodulin bind to overlapping, but nonidentical, sites on RyR1 and that cysteine 3635 is close to or within the apocalmodulin-binding site on RyR1. This cysteine is also one of the cysteines that form the intersubunit disulfide bonds, suggesting that calmodulin binds at an intersubunit contact site. Our findings are consistent with a model in which oxidants regulate the activity of RyR1 directly by altering subunit-subunit interactions and indirectly by preventing the binding of either Ca2+-bound calmodulin or apocalmodulin. NO also has both a direct and an indirect effect: it blocks the ability of oxidants to generate intersubunit disulfide bonds and prevents apocalmodulin binding.

MeSH Terms
Alkylation Animals Binding Sites Calcium Signaling/drug effects,physiology Calmodulin/metabolism,pharmacology Cysteine/physiology Cystine/metabolism Ethylmaleimide/pharmacology Hydrogen Peroxide/pharmacology Ion Transport/drug effects Muscle Contraction/drug effects Muscle Proteins/chemistry,drug effects,metabolism Muscle, Skeletal/metabolism,ultrastructure Myocardial Contraction/drug effects Myocardium/metabolism,ultrastructure Nitric Oxide Donors/pharmacology Oxidants/pharmacology Oxidation-Reduction Protein Binding/drug effects Protein Conformation/drug effects Protein Isoforms/chemistry,drug effects,metabolism Reactive Oxygen Species Reducing Agents/pharmacology Ryanodine Receptor Calcium Release Channel/chemistry,drug effects,metabolism Sarcoplasmic Reticulum/drug effects,metabolism Sulfhydryl Compounds/pharmacology
Chemicals
Calmodulin Muscle Proteins Nitric Oxide Donors Oxidants Protein Isoforms Reactive Oxygen Species Reducing Agents Ryanodine Receptor Calcium Release Channel Sulfhydryl Compounds Cystine Hydrogen Peroxide Cysteine Ethylmaleimide
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Hamilton S L
Department of Molecular Physiology & Biophysics, Baylor College of Medicine, Houston, TX 77030, USA. [email protected]
Reid M B
Article Info
Journal
Antioxidants & redox signaling
Abbr.
Antioxid Redox Signal
ISSN
1523-0864
Published
2000-00-00
Pages
41-5
Language
English
Region
United States
NLM ID
100888899
Subset
IM
Grants
NIAMS NIH HHS · AR 41729 · United States
NIAMS NIH HHS · AR 41802 · United States
NHLBI NIH HHS · HL45721 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]